2005 US NIH Study Found Chloroquine Was Effective in Treating DTMNBN In Primates — Why Was This Ignored?

It is understandable that President Trump and other elected officials on both sides of the aisle may not have been aware of this study, but surely scientists and doctors who have studied DTMNBN (Disease That Must Not Be Named) and it’s many forms would be aware that in 2005, it was determined that chloroquine was found to be effective against DTMNBN in primates and therefore that was a good indication it could also work with humans.

We might have been able to nip this in the butt sooner…

Dr Fauci is one of the world’s leading authorities on DTMNBN and when he said that it wasn’t a magic elixer, he must have known about the 2005 study and considering there have been three international tests with all three seeing a 100% recovery within  days, it should have been obvious that we were onto something big.

Three tests with 100% of those given the drug fully recovering in six days or less should not have been dismissed so easily.

From the article.

Background
Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.

Results
We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.

In addition to the well-known functions of chloroquine such as elevations of endosomal pH, the drug appears to interfere with terminal glycosylation of the cellular receptor, angiotensin-converting enzyme 2. This may negatively influence the virus-receptor binding and abrogate the infection, with further ramifications by the elevation of vesicular pH, resulting in the inhibition of infection and spread of SARS CoV at clinically admissible concentrations.

Conclusion
Chloroquine is effective in preventing the spread of SARS CoV in cell culture.

Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection. In addition, the indirect immunofluorescence assay described herein represents a simple and rapid method for screening SARS-CoV antiviral compounds.

Leave a Reply

Your email address will not be published. Required fields are marked *

get the newsletter

Receive infrequent Floglegs updates about upcoming episodes and general news.